Showing results (101-110 of 319) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium studyNancy B Davis, David A Taber, Rafat H Ansari, et al.Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.Investigational New Drugs|August 31, 2010
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Kristen Wroblewski, James A Wallace, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 1, 2012
Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Michael J Kelley, Jeffrey A Bogart, Lydia D Hodgson, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2010
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trialNeal Ready, Pasi A Jänne, Jeffrey Bogart, et al.Clinical Lung Cancer|November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trialEzra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.International Journal of Radiation Oncology, Biology, Physics|October 11, 2005
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinomaJoseph K Salama, Everett E Vokes, Steven J Chmura, et al.Investigational New Drugs|September 1, 2005
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancersHedy L Kindler, Peter K Tothy, Robert Wolff, et al.Oncotarget|February 10, 2018
Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancerLili Ren, Tatsuo Matsuda, Boya Deng, et al.Anti-Cancer Drugs|September 4, 2008
Protein kinase C beta in malignant pleural mesotheliomaLeonardo Faoro, Sivakumar Loganathan, Maria Westerhoff, et al.Pageof 32